CI Investments Inc
BEAM icon

CI Investments Inc’s Beam Therapeutics BEAM Stock Holding History

CI Investments Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,340
Closed -$85K – 1297
2025
Q1 		$85K Sell
4,340
-20
-0.5% -$524 ﹤0.01% 956
2024
Q4 		$108K Sell
4,360
-480
-10% -$12.3K ﹤0.01% 920
2024
Q3 		$119K Buy
4,840
+36
+0.7% +$930 ﹤0.01% 805
2024
Q2 		$113K Buy
4,804
+1,046
+28% +$25.7K ﹤0.01% 777
2024
Q1 		$124K Buy
3,758
+3
+0.1% +$93 ﹤0.01% 823
2023
Q4 		$102K Buy
3,755
+777
+26% +$19.3K ﹤0.01% 828
2023
Q3 		$72K Sell
2,978
-89
-3% -$2.39K ﹤0.01% 889
2023
Q2 		$98K Buy
3,067
+985
+47% +$32K ﹤0.01% 789
2023
Q1 		$64K Sell
2,082
-27
-1% -$1.07K ﹤0.01% 838
2022
Q4 		$82K Buy
2,109
+1,593
+309% +$71.4K ﹤0.01% 801
2022
Q3 		$25K Sell
516
-38
-7% -$2.17K ﹤0.01% 989
2022
Q2 		$21K Buy
554
+237
+75% +$9.42K ﹤0.01% 966
2022
Q1 		$18K Buy
+317
New +$20.8K ﹤0.01% 1056

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CI Investments Inc's BEAM Position: Q2 2025 in Review

CI Investments Inc sold out of Beam Therapeutics (BEAM) in Q2 2025, closing a stake of 4,340 shares — an estimated $85K sold.

CI Investments Inc first reported a position in BEAM in Q1 2022 and held it in 13 quarters. The position peaked at $124K in Q1 2024. 217 funds tracked by Wall St. Rank hold BEAM as of Q2 2025.

  • CI Investments Inc reported no remaining Beam Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 4,340 Beam Therapeutics shares in Q2 2025, an estimated $85K.
  • CI Investments Inc first reported a position in Beam Therapeutics in Q1 2022 and held it in 13 quarters.
  • CI Investments Inc's Beam Therapeutics position peaked at $124K in Q1 2024.
  • 217 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.